Helix BioPharma (TSE:HBP) Share Price Passes Above Fifty Day Moving Average of $0.18

Helix BioPharma Corp. (TSE:HBP)’s share price passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$0.18 and traded as high as C$0.20. Helix BioPharma shares last traded at C$0.20, with a volume of 2,000 shares traded.

Helix BioPharma Price Performance

The company has a current ratio of 1.46, a quick ratio of 1.04 and a debt-to-equity ratio of 773.67. The stock has a market cap of C$44.74 million, a price-to-earnings ratio of -6.50 and a beta of -0.74. The stock has a 50-day moving average price of C$0.18 and a two-hundred day moving average price of C$0.20.

About Helix BioPharma

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging.